Cargando…

Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics

The β-lactamase of Mycobacterium tuberculosis, BlaC, is susceptible to inhibition by clavulanic acid. The ability of this enzyme to escape inhibition through mutation was probed using error-prone PCR combined with functional screening in Escherichia coli. The variant that was found to confer the mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Elings, Wouter, Chikunova, Aleksandra, van Zanten, Danny B., Drenth, Ralphe, Ahmad, Misbha Ud Din, Blok, Anneloes J., Timmer, Monika, Perrakis, Anastassis, Ubbink, Marcellus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284444/
https://www.ncbi.nlm.nih.gov/pubmed/34031049
http://dx.doi.org/10.1128/AAC.02628-20
_version_ 1783723396883808256
author Elings, Wouter
Chikunova, Aleksandra
van Zanten, Danny B.
Drenth, Ralphe
Ahmad, Misbha Ud Din
Blok, Anneloes J.
Timmer, Monika
Perrakis, Anastassis
Ubbink, Marcellus
author_facet Elings, Wouter
Chikunova, Aleksandra
van Zanten, Danny B.
Drenth, Ralphe
Ahmad, Misbha Ud Din
Blok, Anneloes J.
Timmer, Monika
Perrakis, Anastassis
Ubbink, Marcellus
author_sort Elings, Wouter
collection PubMed
description The β-lactamase of Mycobacterium tuberculosis, BlaC, is susceptible to inhibition by clavulanic acid. The ability of this enzyme to escape inhibition through mutation was probed using error-prone PCR combined with functional screening in Escherichia coli. The variant that was found to confer the most inhibitor resistance, K234R, as well as variant G132N that was found previously were characterized using X-ray crystallography and nuclear magnetic resonance (NMR) relaxation experiments to probe structural and dynamic properties. The G132N mutant exists in solution in two almost equally populated conformations that exchange with a rate of ca. 88 s(−1). The conformational change affects a broad region of the enzyme. The crystal structure reveals that the Asn132 side chain forces the peptide bond between Ser104 and Ile105 in a cis-conformation. The crystal structure suggests multiple conformations for several side chains (e.g., Ser104 and Ser130) and a short loop (positions 214 to 216). In the K234R mutant, the active-site dynamics are significantly diminished with respect to the wild-type enzyme. These results show that multiple evolutionary routes are available to increase inhibitor resistance in BlaC and that active-site dynamics on the millisecond time scale are not required for catalytic function.
format Online
Article
Text
id pubmed-8284444
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-82844442022-01-16 Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics Elings, Wouter Chikunova, Aleksandra van Zanten, Danny B. Drenth, Ralphe Ahmad, Misbha Ud Din Blok, Anneloes J. Timmer, Monika Perrakis, Anastassis Ubbink, Marcellus Antimicrob Agents Chemother Mechanisms of Resistance The β-lactamase of Mycobacterium tuberculosis, BlaC, is susceptible to inhibition by clavulanic acid. The ability of this enzyme to escape inhibition through mutation was probed using error-prone PCR combined with functional screening in Escherichia coli. The variant that was found to confer the most inhibitor resistance, K234R, as well as variant G132N that was found previously were characterized using X-ray crystallography and nuclear magnetic resonance (NMR) relaxation experiments to probe structural and dynamic properties. The G132N mutant exists in solution in two almost equally populated conformations that exchange with a rate of ca. 88 s(−1). The conformational change affects a broad region of the enzyme. The crystal structure reveals that the Asn132 side chain forces the peptide bond between Ser104 and Ile105 in a cis-conformation. The crystal structure suggests multiple conformations for several side chains (e.g., Ser104 and Ser130) and a short loop (positions 214 to 216). In the K234R mutant, the active-site dynamics are significantly diminished with respect to the wild-type enzyme. These results show that multiple evolutionary routes are available to increase inhibitor resistance in BlaC and that active-site dynamics on the millisecond time scale are not required for catalytic function. American Society for Microbiology 2021-07-16 /pmc/articles/PMC8284444/ /pubmed/34031049 http://dx.doi.org/10.1128/AAC.02628-20 Text en Copyright © 2021 Elings et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Mechanisms of Resistance
Elings, Wouter
Chikunova, Aleksandra
van Zanten, Danny B.
Drenth, Ralphe
Ahmad, Misbha Ud Din
Blok, Anneloes J.
Timmer, Monika
Perrakis, Anastassis
Ubbink, Marcellus
Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
title Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
title_full Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
title_fullStr Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
title_full_unstemmed Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
title_short Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
title_sort two β-lactamase variants with reduced clavulanic acid inhibition display different millisecond dynamics
topic Mechanisms of Resistance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284444/
https://www.ncbi.nlm.nih.gov/pubmed/34031049
http://dx.doi.org/10.1128/AAC.02628-20
work_keys_str_mv AT elingswouter twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT chikunovaaleksandra twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT vanzantendannyb twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT drenthralphe twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT ahmadmisbhauddin twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT blokanneloesj twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT timmermonika twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT perrakisanastassis twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics
AT ubbinkmarcellus twoblactamasevariantswithreducedclavulanicacidinhibitiondisplaydifferentmilliseconddynamics